Is CD36 gene polymorphism in region encoding lipid-binding domain associated with early onset CAD?

CD36 is a fatty acid translocase in striated muscle cells and cardiomyocytes. Some study suggested that alterations in CD36 gene may be associated with coronary artery disease (CAD) risk. The aim of the current study was to compare the frequency of CD36 variants in region encoding lipid-binding domain in Caucasian patients with early-onset CAD, no-CAD adult controls and neonates. The study group comprised 100 patients with early onset CAD. The genetic control groups were 306 infants and 40 no-CAD adults aged over 70 years. Exons 4, 5 and 6 including fragments of flanking introns were studied using the denaturing high-performance liquid chromatography technique and direct sequencing. Changes detected in analyzed fragment of CD36: IVS3-6 T/C (rs3173798), IVS4-10 G/A (rs3211892), C311T (Thr104Ile, not described so far) in exon 5, G550A (Asp184Asn, rs138897347), C572T (Pro191Leu, rs143150225), G573A (Pro191Pro, rs5956) and A591T (Thr197Thr, rs141680676) in exon 6. No significant differences in the CD36 genotype, allele and haplotype frequencies were found between the three groups. Only borderline differences (p = 0.066) were found between early onset CAD patients and newborns in the frequencies of 591T allele (2.00% vs 0.50%) and CGCGCGT haplotype (2.00% vs 0.50%) with both IVS3-6C and 591T variant alleles. In conclusion, CD36 variants: rs3173798, rs3211892, rs138897347, rs5956, rs143150225 rs141680676 and C311T do not seem to be involved in the risk of early-onset CAD in Caucasian population.     

PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females

Background and aim

PSCA is a tissue specific tumor suppressor or oncogene which has been found to be associated with several human tumors including gallbladder cancer. It is considered to be involved in the cell-proliferation inhibition and/or cell-death induction activity. Therefore, we aimed to investigate the role of PSCA gene polymorphisms in gallbladder cancer risk in North Indian population.

Methodology

A total of 405 gallbladder cancer patients and 247 healthy controls were included in the case–control study for risk prediction. We examined the association of two functional SNPs, rs2294008 and rs2978974 in PSCA gene by genotyping using Taqman allelic discrimination assays. Statistical analysis was done using SPSS software, version 17. Linkage disequilibrium and haplotype analysis was done with the help of SNPstats software. FDR test was used to correct for multiple comparisons.

Results

No significant associations of rs2294008 and rs2978974 genetic variants of the PSCA gene were found with GBC risk at allele, genotype or haplotype levels. Stratifying the subjects on the basis of gallstone also did not show any significant result. However, on gender stratification, we found a significant association of T_rs2294008-G_rs2978974 haplotype with higher risk of GBC in females (FDR Pcorr = 0.021, OR = 1.6). In contrary, T_rs2294008-A _rs2978974 haplotype conferred significant lower risk in males (FDR Pcorr = 0.013; OR = 0.25).

Conclusions

These findings suggest that PSCA genetic variants may have a significant effect on GBC susceptibility in a gender specific manner.     

Hemocyanin gene family evolution in spiders (Araneae), with implications for phylogenetic relationships and divergence times in the infraorder Mygalomorphae

Hemocyanins are multimeric copper-containing hemolymph proteins involved in oxygen binding and transport in all major arthropod lineages. Most arachnids have seven primary subunits (encoded by paralogous genes a–g), which combine to form a 24-mer (4 × 6) quaternary structure. Within some spider lineages, however, hemocyanin evolution has been a dynamic process with extensive paralog duplication and loss. We have obtained hemocyanin gene sequences from numerous representatives of the spider infraorders Mygalomorphae and Araneomorphae in order to infer the evolution of the hemocyanin gene family and estimate spider relationships using these conserved loci. Our hemocyanin gene tree is largely consistent with the previous hypotheses of paralog relationships based on immunological studies, but reveals some discrepancies in which paralog types have been lost or duplicated in specific spider lineages. Analyses of concatenated hemocyanin sequences resolved deep nodes in the spider phylogeny and recovered a number of clades that are supported by other molecular studies, particularly for mygalomorph taxa. The concatenated data set is also used to estimate dates of higher-level spider divergences and suggests that the diversification of extant mygalomorphs preceded that of extant araneomorphs. Spiders are diverse in behavior and respiratory morphology, and our results are beneficial for comparative analyses of spider respiration. Lastly, the conserved hemocyanin sequences allow for the inference of spider relationships and ancient divergence dates.     

Locating QTLs controlling several adult root traits in an elite Chinese hybrid rice

This study aimed to elucidate the genetics of the adult root system in elite Chinese hybrid rice. Several adult root traits in a recombinant inbred line (RIL) population of Xieyou 9308 and two backcross F₁ (BCF₁) populations derived from the RILs were phenotyped under hydroponic culture at heading stage for quantitative trait locus (QTL) mapping and other statistical analysis. There a total of eight QTLs detected for the root traits. Among of them, a pleiotropic QTL was repeatedly flanked by RM180 and RM5436 on the short arm of chromosome 7 for multiple traits across RILs and its BCF₁ populations, accounting for 6.88% to 25.26% of the phenotypic variances. Only additive/dominant QTLs were detected for the root traits. These results can serve as a foundation for facilitating future cloning and molecular breeding.     

Relationship between CCR2-V64I polymorphism and cancer risk: A meta-analysis

Background and objectives

The role of CCR2-V64I polymorphism in various cancers has been reported in many studies. However, results from published studies on the association between CCR2-V64I polymorphism and cancer risk are conflicting. Therefore, we performed a meta-analysis to estimate the overall cancer risk associated with the polymorphism.

Methods

Electronic searches of PubMed and EMBASE were conducted for all publications on the association between this variant and cancer. Odds ratios (OR) with 95% confidence intervals (95% CI) were used to access the strength of this association.

Results

Sixteen studies with 2661 cancer patients and 5801 healthy controls were included. Overall, significant association was found between the CCR2-V64I polymorphism and cancer risk (OR = 1.84, 95% CI = 1.35–2.51, AA vs GA/GG, P = 0.37). In the subgroup analysis stratified by cancer types, there was a significant association between this polymorphism and bladder cancer (OR = 2.06, 95% CI = 1.02–4.15, AA vs GA/GG, P = 0.11), cervical cancer (OR = 3.34, 95% CI = 1.48–7.50, AA vs GG, P = 0.56), and oral cancer (OR = 2.04, 95% CI = 1.46–2.84, GA vs GG, P = 0.70). In the subgroup analysis stratified by ethnicities, an increased cancer risk was also found in Europeans (OR = 2.31, 95% CI = 1.45–3.68, AA vs GA/GG, P = 0.16) and Asians (OR = 1.88, 95% CI = 1.12–3.16, AA vs GA/GG, P = 0.92).

Conclusion

This meta-analysis suggested that CCR2-V64I polymorphism may contribute to an increased risk of cancer.     

1790 G/A polymorphism,but not 1772 C/T polymorphism,is significantly associated with Cancers: An update study

This study aimed to investigate the association between PASD8 gene and cancers. For 1772 C/T polymorphism (rs11549465), it included 5552 cases and 8044 controls, and for 1790 G/A (rs11549467), 3381 cases and 5830 controls. The allele-analysis results showed that 1772 C/T (rs11549465) was significantly associated with cancers (OR: 1.177, 95% CI: 1.011–1.369, p = 0.035). And results of genotype-analysis indicated that 1790 G/A (rs11549467) had a significant relationship with cancers. (OR: 0.736, 95% CI: 0.595–0.910, p = 0.005). For 1790 G/A (rs11549467), the association was significant when subdivided by different kinds of cancers. And no association existed when subdivided into population-type subgroups. In conclusion, PASD8 gene played an important role in the development of cancers.     

Circadian Variation of Cardiac Performance in Coronary Heart Disease

To study the circadian variation of cardiac performance in patients with coronary heart disease, three exercise tests on a bicycle crgometer were performed during the active part of the day (10 a.m., 2 p.m. and 6 p.m.), recording ST-segment depression and pulmonary capillary wedge pressure. Ten male patients with angiographically documented coronary heart disease underwent bicycle ergometry during placebo and during nitrate therapy (placebo controlled, double-blind crossover 2 × 20 mg IS-5-MN and 1 × 120 mg ISDN sustained release). During placebo as well as during nitrate therapy there was a gradual decrease of cardiac performance during the day, documented by the increase in ST-depression and pulmonary capillary wedge pressure at equal work loads. High nitrate concns led to a significant reduction of both ST-depression and preload with a marked circadian-phase dependency of cardiovascular effects.     

斑点叉尾和杂交鲟幼鱼昼夜摄食节律和胃肠排空时间的研究

采用一次饱食投喂(将一昼夜分为8个时间段,每个时间段作为一个处理组,每天每个处理组饱食投喂一次)和分段式连续投喂(将一昼夜分为8个时间段,每天每个实验缸连续投喂8次)两种方法研究斑点叉尾和杂交鲟幼鱼的昼夜摄食节律,同时研究它们在摄食后24h内胃和全肠的排空时间。结果显示,在两种投喂方式下,斑点叉尾均表现出24h 一周期的摄食节律,两个日摄食率高峰值均出现在06：00和18：00(P<0.05)。杂交鲟在一次饱食投喂下表现出24h一周期的摄食节律,高峰值分别出现在11：00、17：00和05：00,在分段式连续投喂时表现出48h 一周期的摄食节律,高峰值分别出现在11：00、17：00和36：00。在摄食后1-9h 内,斑点叉尾的胃内含物比率急剧降低(P<0.05),并在24h 时出现极低值(P<0.05),而1-9h 内全肠内含物比率迅速升高(P<0.05),在9h时达到最大(P<0.05),在24h出现极低值(P<0.05)。在摄食后1-7h内,杂交鲟的胃内含物比率迅速下降(P<0.05),在24h 时出现极低值(P<0.05),1-7h 内肠内含物比率迅速升高(P<0.05),24h 时呈现极低值(P<0.05)。结果表明,两种实验鱼表现出不同的昼夜摄食节律,该节律受各自胃肠排空时间的影响,也受投喂时间的影响。研究建议,在斑点叉尾和杂交鲟幼鱼的养殖中宜在光线较弱的清晨(05：00-06：00)和黄昏(17：00-18：00)进行投喂。     

应用意愿价值评估法评价河流生态恢复的时间稳定性——以上海城市内河为例

意愿价值评估法 (CVM)的评估结果是否具有时间稳定性是其可靠性检验中的重要问题,决定其能否应用于我国的生态系统服务价值评估.本文以上海城市内河生态恢复为评估对象,设计相隔1个月和2年的3次意愿价值评估方案,分别对3次调查的426、498和200份问卷进行了对比分析.结果表明： 3次支付意愿均值分别为14.2、14.1和18.0元,中位数分别为5、5和10元.进一步对支付意愿分布和主要统计值、影响因素、模型时间变量的显著性分析结果表明,相隔1个月的CVM 结果具有时间上的稳定性,而相隔2年的CVM 结果表现出一定差异.     

Association between age at first calving,year and season of first calving and milk production in Holstein cows

The effects of first calving (FC) in Holstein heifers on their first lactation, second lactation and lifetime milk production were examined from an initial database of 459 743 animals that first calved between 1 January 1990 and 31 July 2010 in Wallonia, Belgium. The FC age class (18 to 22, 22 to 26, 26 to 30, 30 to 34, 34 to 38 and 38 to 42 months), the FC season and FC year class (1990 to 1994, 1995 to 1999, 2000 to 2004 and 2005 to 2010) were considered when analysing the first and second lactation data. Lifetime data were similarly analysed, but did not include animals that calved after 2005 because many of them were still lactating. Only 24% of animals had their FC before 26 months of age. Animals that first calved between 22 and 26 months of age had more lactations and productive days during their life. They also had higher first and second lactation milk production and lifetime milk production. Summer or autumn FC improved first lactation, second lactation and lifetime milk production, as well as production per day of lactation, compared with winter or spring FC. Compared with animals that calved for the first time in 1990 to 1994, animals with a FC in 2000 to 2004 had a longer calving interval (0.5 months), fewer lactations per animal (−0.6) and fewer days in their lifetime lactation (a reduction of 144 days). As a result, the animals’ lifetime production did not increase between 1990 to 1994 and 2000 to 2004, although milk production per day of lactation (22.85v. 20.49 l/day) and per day of life (11.49v. 10.78 l/day) improved. Milk fat content was lower in 2000 to 2004 than in 1990 to 1994, but protein content remained relatively constant, probably because of the cows’ higher production level and increased dietary concentrate supplementation.